Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebivolol and Timolol EyeSol in Glaucoma and Ocular Hypertension
NCT04910100Phase 2Completed
- Sponsor
- Betaliq, Inc.
- Start
- Apr 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nebivolol in open-angle glaucoma (OAG), ocular hypertension, sponsored by Betaliq, Inc.. Started Apr 2021; status: completed.
02
Drugs
nebivolol
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT04910100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04910100.